Cargando…

Safety of Dual‐Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease

BACKGROUND: Although recommended in the guidelines, the safety of chronic P2Y(12) inhibitor therapy in patients with chronic kidney disease (CKD) after an acute myocardial infarction (MI) is not well studied. METHODS AND RESULTS: The TRANSLATE‐ACS (Treatment with ADP Inhibitors: Longitudinal Assessm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rymer, Jennifer A., Kaltenbach, Lisa A., Doll, Jacob A., Messenger, John C., Peterson, Eric D., Wang, Tracy Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585341/ https://www.ncbi.nlm.nih.gov/pubmed/31070112 http://dx.doi.org/10.1161/JAHA.119.012236

Ejemplares similares

Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE‐ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome) Study
por: Fanaroff, Alexander C., et al.
Publicado: (2018)

Magnitude and Characteristics of Patients Who Survived an Acute Myocardial Infarction
por: Tisminetzky, Mayra, et al.
Publicado: (2017)

Readmissions After Acute Myocardial Infarction: How Often Do Patients Return to the Discharging Hospital?
por: Rymer, Jennifer A., et al.
Publicado: (2019)

Single and dual antiplatelet therapy in elderly patients of medically managed myocardial infarction
por: Lin, Ting-Tse, et al.
Publicado: (2018)

Dual antiplatelet therapy in a patient with simultaneous aneurysmal subarachnoid hemorrhage and myocardial infarction
por: Mortazavi, Abolghasem, et al.
Publicado: (2020)

Challenge in Predicting Persistence to P2Y12 Inhibitors: A Perspective From the ARTEMIS Trial
por: Rymer, Jennifer A., et al.
Publicado: (2023)

Lipid Testing and Statin Dosing After Acute Myocardial Infarction
por: Wang, William T., et al.
Publicado: (2018)

Advanced Practice Provider Versus Physician‐Only Outpatient Follow‐Up After Acute Myocardial Infarction
por: Rymer, Jennifer A., et al.
Publicado: (2018)

Variation in Practice Regarding Pretreatment With Dual Antiplatelet Therapy for Patients With Non–ST Elevation Myocardial Infarction
por: Shafiq, Ali, et al.
Publicado: (2016)

Meta-analysis Comparing Outcomes of Type 2 Myocardial Infarction and Type 1 Myocardial Infarction With a Focus on Dual Antiplatelet Therapy
por: Reid, Christopher, et al.
Publicado: (2020)

Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction
por: Weiss, Thomas W., et al.
Publicado: (2016)

Impact of preprocedural coronary flow grade on duration of dual antiplatelet therapy in acute myocardial infarction
por: Kim, Yong Hoon, et al.
Publicado: (2021)

Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE‐ACS Study
por: Fanaroff, Alexander C., et al.
Publicado: (2017)

Significance of antiplatelet therapy in emergency myocardial infarction treatment
por: Komosa, Anna, et al.
Publicado: (2014)

Interaction of Panax quinquefolius Saponin and Dual Antiplatelets on Vascular Endothelial Function in Rats with Acute Myocardial Infarction
por: Wang, Baojun, et al.
Publicado: (2015)

Clinical Impact of Single and Dual Antiplatelet Therapy Beyond 12 Months on Ischemic Risk in Patients With Acute Myocardial Infarction
por: Roh, Ji Woong, et al.
Publicado: (2021)

Spinal cord hemorrhage: a rare complication of dual antiplatelet therapy for non-ST elevation myocardial infarction
por: Yu, Xing, et al.
Publicado: (2019)

Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction – A 13-year nationwide cohort study
por: Wu, Victor Chien-Chia, et al.
Publicado: (2019)

Aspirin Monotherapy beyond 12 Months of Dual Antiplatelet Therapy in Patients with Acute Myocardial Infarction: Oldies But Goodies?
por: Suh, Jung-Won
Publicado: (2019)

Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST‐segment elevation myocardial infarction
por: Welsh, Robert C., et al.
Publicado: (2021)

Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms
por: Samaniego, Edgar A, et al.
Publicado: (2019)

The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study
por: Wang, Mei-Tzu, et al.
Publicado: (2018)

Cardiovascular Safety of Celecoxib on Top of Dual Antiplatelet Therapy
por: Hong, Bum-Kee
Publicado: (2010)

Comparing the effectiveness and safety of dual antiplatelet with ticagrelor or clopidogrel in elderly Asian patients with acute myocardial infraction
por: Yeh, Jong-Shiuan, et al.
Publicado: (2023)

Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease
por: Kao, Chih-Chin, et al.
Publicado: (2021)

Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
por: Solheim, Svein, et al.
Publicado: (2013)

Clopidogrel versus Aspirin after Dual Antiplatelet Therapy in Acute Myocardial Infarction Patients Undergoing Drug-Eluting Stenting
por: Sim, Doo Sun, et al.
Publicado: (2019)

Dual antiplatelet therapy before coronary artery bypass grafting in patients with myocardial infarction: a prospective cohort study
por: Sadeghi, Roxana, et al.
Publicado: (2021)

Multivessel Versus Culprit Vessel–Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE‐ACS Observational Study
por: Ibrahim, Homam, et al.
Publicado: (2017)

Initiation and persistence with dual antiplatelet therapy after acute myocardial infarction: a Danish nationwide population-based cohort study
por: Green, Anders, et al.
Publicado: (2016)

Pulmonary alveolar hemorrhage mimicking a pneumopathy: a rare complication of dual antiplatelet therapy for ST elevation myocardial infarction
por: Oualim, Sara, et al.
Publicado: (2016)

MiR-223 or miR-126 predicts resistance to dual antiplatelet therapy in patients with ST-elevation myocardial infarction
por: Li, Xiaojing, et al.
Publicado: (2021)

Clinical benefit of long-term use of dual antiplatelet therapy for acute myocardial infarction patients with the PEGASUS-TIMI 54 criteria
por: Lee, Kwan Yong, et al.
Publicado: (2022)

Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors
por: Pasea, Laura, et al.
Publicado: (2017)

Triple Antiplatelet Therapy with Cilostazol and Favorable Early Clinical Outcomes after Acute Myocardial Infarction Compared to Dual Antiplatelet Therapy with Standard or Potent P2Y12 Inhibitors
por: Byun, Sungwook, et al.
Publicado: (2022)

Change in Angina Symptom Status After Acute Myocardial Infarction and Its Association With Readmission Risk: An Analysis of the Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH) Registry
por: Doll, Jacob A., et al.
Publicado: (2016)

Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction
por: Lotfollahi, Zahra, et al.
Publicado: (2022)

Difference in Medication Adherence Between Patients Prescribed a 30‐Day Versus 90‐Day Supply After Acute Myocardial Infarction
por: Rymer, Jennifer A., et al.
Publicado: (2020)

Does the Effectiveness of a Medicine Copay Voucher Vary by Baseline Medication Out‐Of‐Pocket Expenses? Insights From ARTEMIS
por: Rymer, Jennifer A., et al.
Publicado: (2022)

Prolonged dual antiplatelet therapy in patients with non‐ST‐segment elevation myocardial infarction: 2‐year findings from EPICOR Asia
por: Zou, Yanan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lo3lik1fc9tf0gaft3rptduouf